Toledo, Spain

José Manuel Bartolomé -Nebreda


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: José Manuel Bartolomé-Nebreda: Innovator in Pharmaceutical Chemistry

Introduction

José Manuel Bartolomé-Nebreda is a notable inventor based in Toledo, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating various mental health disorders.

Latest Patents

Bartolomé-Nebreda holds a patent for "Fused heterocyclic isoxazoline derivatives and their use as anti-depressants." This invention focuses on fused heterocyclic isoxazoline derivatives that have been shown to possess selective serotonin (5-HT) reuptake inhibitor activity and α-adrenoceptor antagonist activity. The compounds are particularly useful in treating depression, anxiety, movement disorders, psychosis, Parkinson's disease, and body weight disorders such as anorexia nervosa and bulimia. The patent outlines the preparation processes, pharmaceutical compositions, and therapeutic applications of these compounds.

Career Highlights

José Manuel Bartolomé-Nebreda is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work has contributed to advancements in mental health treatments, showcasing his expertise in medicinal chemistry.

Collaborations

He has collaborated with notable colleagues such as José Ignacio Andrés-Gil and Manuel Jesús Alcázar-Vaca, further enhancing the impact of his research and innovations in the pharmaceutical field.

Conclusion

José Manuel Bartolomé-Nebreda's contributions to pharmaceutical chemistry, particularly through his patented inventions, highlight his role as an innovator in developing treatments for mental health disorders. His work continues to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…